Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer

Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and... This systematic review examines the association of immune checkpoint inhibitor therapy with immune-related adverse effects, antitumor activity, and viral load in patients with HIV infection and advanced-stage cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer

JAMA Oncology , Volume 5 (7) – Jul 7, 2019

Loading next page...
 
/lp/american-medical-association/safety-and-efficacy-of-immune-checkpoint-inhibitor-therapy-in-patients-Llg1ZpYMbu

References (41)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2018.6737
Publisher site
See Article on Publisher Site

Abstract

This systematic review examines the association of immune checkpoint inhibitor therapy with immune-related adverse effects, antitumor activity, and viral load in patients with HIV infection and advanced-stage cancer.

Journal

JAMA OncologyAmerican Medical Association

Published: Jul 7, 2019

There are no references for this article.